Chemoinformaics analysis of (+)-Alpha-Vetivone
Molecular Weight | 218.34 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
Exact Molecular Weight | 218.167 | nRing | 2 |
Solubility: LogS | -3.715 | nHRing | 0 |
Solubility: LogP | 3.615 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 40.5214 |
nHD | 0 | BPOL | 22.9386 |
QED | 0.561 |
Synth | 4.347 |
Natural Product Likeliness | 2.777 |
NR-PPAR-gamma | 0.436 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.907 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.614 |
MDCK | 0.0000227 |
BBB | 0.946 |
PPB | 0.884188 |
VDSS | 1.851 |
FU | 0.0658217 |
CYP1A2-inh | 0.115 |
CYP1A2-sub | 0.198 |
CYP2c19-inh | 0.249 |
CYP2c19-sub | 0.835 |
CYP2c9-inh | 0.278 |
CYP2c9-sub | 0.763 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.341 |
CYP3a4-inh | 0.146 |
CYP3a4-sub | 0.307 |
CL | 15.037 |
T12 | 0.6 |
hERG | 0.006 |
Ames | 0.016 |
ROA | 0.017 |
SkinSen | 0.544 |
Carcinogencity | 0.922 |
EI | 0.921 |
Respiratory | 0.953 |
NR-Aromatase | 0.025 |
Antiviral | Yes |
Prediction | 0.878764 |